CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership established in 2017 to accelerate the development...

CEPI and the Gates Foundation launched GS-LEARN to provide rapid epidemic modeling for future infectious disease threats by January 15, 2025...

CEPI and the U.S. International Development Finance Corporation announced a collaboration to enhance global health security by investing in vaccine initiatives and exploring pandemic financing tools...

CEPI signed strategic agreements with Bio-Manguinhos to expand technological capabilities focusing on RNA and viral vector platforms...

In 2024, CEPI expanded its manufacturing network to India and Brazil and initiated Phase 2 clinical trials for a Lassa fever vaccine...

CEPI is establishing vaccine safety benchmarking in Africa specifically for African vaccines...

CEPI is funding up to $10.3 million for the ACHIEVE study on chikungunya over three years...